About OZOP Surgical, Inc.Superior Equipment For Minimally Invasive Surgery
The OZOP Surgical Story
OZOP Surgical, Inc. (“OZOP”), a wholly owned subsidiary of Ozop Surgical Corp. (OTCPK:OZSC), invents, designs, develops, manufactures and globally distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers.
The Company controls an IP portfolio of innovative products and technologies that it is beginning to successfully commercialize. In the pipeline products include visualization tools for MIS such as light filtration that presents a better anatomical understanding for surgeons in real time, and 3D technology which heralds improved depth perception, better appreciation of anatomic details, and improved overall surgical performance. Also in development is a revolutionary orthopedic device and procedure, the first truly MIS interbody device and procedure.
OZOP Surgical Executive Management Team
In 1998, he was the co-founder, initial investor and original Chairman of Medibuy.com, an Internet healthcare supply vendor. Medibuy raised over $140 million in its first 18 months of operation backed by leading VCs such as Kleiner Perkins, Sequoia, Oak, and institutional investors including Alianz. Medibuy acquired the ecommerce initiatives of two leading GPOs, Premier and Columbia HCA, that at one time accounted for nearly 70% of healthcare product expenditures in the US. Medibuy was sold to GHX (Global Health Exchange), an ecommerce company founded by General Electric, Abbot, Baxter, Medtronic. Becton-Dickinson, Braun, Guidant, Tyco, Siemens and others.
He worked in China for over 6 years and was the former Chairman and CEO of Bridgetech Holdings International (OTC: BGTH), which focused on introducing western medicine into China. He has served on the Board of Directors and as an Audit Committee member of Beijing Origin Seed (NASDAQ: SEED).
Michael graduated from the University of New Mexico, Anderson School of Management. Michael and his wife funded and run a 501c3 focused on animal rescue and the support of rescue organizations.
OZOP is an extension of his expertise on Spine and Neuro endoscopes; and his focus on molecular MIS recognizes the future potential for endoscope systems. His experience in product development and in the laboratory add stability and bring tremendous value to the company as it pursues its great future.
He has established academic research collaborations with the Chinese University of Hong Kong and Hong Kong University as well as leading institutions in the PRC. He has a long history of collaboration with the MOH (Ministry of Health) where he has organized over 200 workshops for leading Chinese surgeons working with international medical device manufacturers as well as the CDA (Chinese Doctors Association) regarding physician and surgeon training and continuing education initiatives. He also has extensive experience in working with China’s regulatory body, the CFDA, and has successfully registered over 100 products for international medical devices manufacturers.
Eric has maintained an office in Tuttlingen Germany for over 15 years where he has sourced products for introduction and sale in the PRC. Eric is a Canadian citizen based in Hong Kong and Beijing with degrees in Applied Mathematics and Physics from the University of London.
From June 2001 until March 2008, he held the position of Vice President, Investment Banking in Gulf International Bank B.S.C. During this time, he led private placements and IPOs in various sectors including manufacturing, banking, hospitality, retail and healthcare. His experience includes corporate restructurings, mergers & acquisitions, valuation of business interests and provision of consultancy services to some of the largest healthcare groups and medical device distributors in the Middle East, including Dallah Healthcare, a leading Saudi hospital group, and El Seif Development Company, the Saudi sole distributor for GE, Draeger, Cerner and other US brands. Prior to GIB, Salman worked as an Associate for RP Associates, a California based venture capital incubator of start-ups focusing on medical devices, B2B internet and other companies. Salman started his career in December 1996 with the Corporate Finance Group of the National Commercial Bank, Saudi Arabia, one of the largest banks in the Middle East.
He holds a BSc. (Hons) degree in Business Management from Kings College, University of London and a MSc. in Accounting and Finance from the London School of Economics.